Dissection of GvHD and GvL by FBTA05, a novel trifunctional anti-CD3 x anti-CD20 antibody

被引：0
|
作者：
Buhmann, R. [1 ]
Stanglmaier, M. [2 ]
Simoes, B. [3 ]
Menzel, H. [4 ]
Peschel, C. [4 ]
Ruf, P. [2 ]
Lindhofer, H. [2 ]
Kolb, H. -J. [3 ]
机构：
[1] LMU, Klinikum Grosshadern, Munich, Germany
[2] TRION Res, Munich, Germany
[3] Helmholtz Zentrum, Munich, Germany
[4] TU, Klinikum Rechts Isar, Munich, Germany
来源：
BONE MARROW TRANSPLANTATION | 2010年 / 45卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S123 / S123
页数：1
相关论文
共 50 条
  • [41] Phase I trial of the trifunctional anti-HER2 x anti-CD3 antibody ertumaxomab in metastatic breast cancer.
    Kiewe, P
    Hasmüller, S
    Kahlert, S
    Heinrigs, M
    Rack, B
    Marmé, A
    Korfel, A
    Thiel, E
    Sommer, H
    Untch, M
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 173S - 173S
  • [42] First Surgical Experience of Intraperitoneal Treatment with the Trifunctional Antibody Catumaxomab (Anti-EpCam x Anti-CD3) for Epithelial Ovarian Cancer
    Papanikolaou, Georgios
    Fotopoulou, Christina
    Braicu, Ioana
    Chekerov, Radoslav
    Schmidt, Sven Christian
    Pietzner, Klaus
    Sehouli, Jalid
    ANTICANCER RESEARCH, 2011, 31 (08) : 2603 - 2608
  • [43] TRANSLATIONAL FINDINGS FOR REGN1979, A HUMAN ANTI-CD20 X ANTI-CD3 BISPECIFIC ANTIBODY: FROM PRECLINICAL TO FIRST-IN-HUMAN STUDY IN PATIENTS WITH CD20+B-CELL MALIGNANCIES.
    Zhu, M.
    Smith, E.
    Kirshner, J.
    Toroghi, M.
    Davis, J.
    Di-Cioccio, A.
    Retter, M.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2020, 107 : S103 - S103
  • [44] Obinutuzumab: a new class of anti-CD20 monoclonal antibody
    Gagez, Anne-Laure
    Cartron, Guillaume
    CURRENT OPINION IN ONCOLOGY, 2014, 26 (05) : 484 - 491
  • [45] Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus
    Arin, MJ
    Engert, A
    Krieg, T
    Hunzelmann, N
    BRITISH JOURNAL OF DERMATOLOGY, 2005, 153 (03) : 620 - 625
  • [46] A Novel Anti-B7-H3 x Anti-CD3 Bispecific Antibody with Potent Antitumor Activity
    Feng, Yan
    Xie, Kun
    Yin, Yanxin
    Li, Bingyu
    Pi, Chenyu
    Xu, Xiaoqing
    Huang, Tao
    Zhang, Jingming
    Wang, Bo
    Gu, Hua
    Fang, Jianmin
    LIFE-BASEL, 2022, 12 (02):
  • [47] The effect of anti-CD20 antibody treatment in cynomolgus monkeys
    Park, Hyojun
    Kwon, Yeongbeen
    Lee, Kyo Won
    Park, Jae Berm
    Kim, Sung Joo
    Kim, Kaabsoo
    Lee, Sanghoon
    Lee, Suk Koo
    XENOTRANSPLANTATION, 2015, 22 : S119 - S119
  • [48] VELTUZUMAB Humanized Anti-CD20 Monoclonal Antibody Oncolytic
    Bhat, S. A.
    Czuczman, M. S.
    DRUGS OF THE FUTURE, 2011, 36 (07) : 519 - 526
  • [49] Donor CD8+ T cells facilitate engraftment and mediate GVL without GVHD in recipients conditioned with anti-CD3 MAB
    Zhang, C
    Lou, J
    Huang, T
    Todorov, I
    Cao, Y
    Contag, C
    Kandeel, F
    Forman, S
    Zeng, D
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2006, 12 (02) : 51 - 51
  • [50] What signals are generated by anti-CD20 antibody therapy?
    Bonavida B.
    Current Hematologic Malignancy Reports, 2006, 1 (4) : 205 - 213
12345